Index DJIA, NDX, S&P 500 P/E - EPS (ttm) -3.64 Insider Own 0.30% Shs Outstand 862.60M Perf Week 0.74%
Market Cap 27.48B Forward P/E 6.62 EPS next Y 4.75 Insider Trans 0.40% Shs Float 714.48M Perf Month -0.54%
Income -3144.00M PEG - EPS next Q 1.09 Inst Own 59.80% Short Float / Ratio 4.76% / 4.73 Perf Quarter -5.53%
Sales 133.29B P/S 0.21 EPS this Y 117.60% Inst Trans -0.06% Short Interest 34.00M Perf Half Y -22.71%
Book/sh 24.57 P/B 1.28 EPS next Y 5.96% ROA -3.30% Target Price 40.00 Perf Year -26.24%
Cash/sh 2.10 P/C 14.93 EPS next 5Y 1.73% ROE -13.50% 52W Range 29.48 - 42.74 Perf YTD -15.90%
Dividend 1.92 P/FCF - EPS past 5Y 5.80% ROI 4.60% 52W High -26.49% Beta 0.72
Dividend % 6.11% Quick Ratio 0.30 Sales past 5Y 2.30% Gross Margin 20.20% 52W Low 6.58% ATR 0.75
Employees 200000 Current Ratio 0.60 Sales Q/Q 3.30% Oper. Margin -6.00% RSI (14) 47.17 Volatility 2.35% 2.22%
Optionable Yes Debt/Eq 0.66 EPS Q/Q -20.20% Profit Margin -2.40% Rel Volume 0.87 Prev Close 31.85
Shortable Yes LT Debt/Eq 0.46 Earnings Jun 27 BMO Payout 38.21% Avg Volume 7.19M Price 31.42
Recom 2.90 SMA20 1.06% SMA50 -5.28% SMA200 -11.43% Volume 6,227,038 Change -1.35%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-23-23 Initiated Loop Capital
Buy
$45
Nov-23-22 Resumed Morgan Stanley
Underweight
$39
Nov-22-22 Upgrade Cowen
Market Perform → Outperform
$43 → $54
Nov-18-22 Upgrade JP Morgan
Neutral → Overweight
$42
Nov-11-22 Upgrade Deutsche Bank
Hold → Buy
Apr-01-22 Downgrade Robert W. Baird
Outperform → Neutral
$70 → $51
Dec-16-21 Downgrade Morgan Stanley
Equal-Weight → Underweight
$56 → $49
Mar-25-21 Reiterated Deutsche Bank
Hold
$49 → $55
Jan-11-21 Upgrade Robert W. Baird
Neutral → Outperform
$55
Jan-11-21 Upgrade Guggenheim
Neutral → Buy
$55
Jan-08-21 Resumed Credit Suisse
Neutral
$42
Apr-06-20 Upgrade UBS
Sell → Neutral
$49 → $44
Apr-03-20 Upgrade Deutsche Bank
Sell → Hold
$51 → $43
Dec-11-19 Downgrade Wells Fargo
Outperform → Market Perform
$65 → $61
Oct-30-19 Reiterated Pivotal Research Group
Hold
$60 → $55
Oct-23-19 Downgrade JP Morgan
Overweight → Neutral
$73 → $63
Sep-27-19 Resumed RBC Capital Mkts
Sector Perform
$59
Sep-12-19 Initiated Deutsche Bank
Sell
Apr-18-19 Initiated Guggenheim
Neutral
$59
Apr-03-19 Reiterated Pivotal Research Group
Hold
$70 → $60
Show Previous Ratings
Jun-10-23 05:00AM Jun-09-23 07:51PM 01:05PM 11:33AM 10:53AM
05:21AM
Loading…
05:21AM Jun-08-23 08:33PM 02:00PM 01:00PM 09:11AM Jun-07-23 05:45PM 04:38PM 01:21PM 09:33AM 05:55AM
12:00PM
Loading…
Jun-06-23 12:00PM Jun-05-23 10:31AM 09:00AM Jun-02-23 10:26AM Jun-01-23 05:45PM 10:15AM 10:00AM 09:00AM May-31-23 08:30AM (American City Business Journals)
May-29-23 07:30PM 10:00AM May-26-23 05:45PM 05:01PM 12:16PM 09:52AM
05:50AM
Loading…
05:50AM 05:21AM May-25-23 08:26AM May-23-23 04:49PM 11:17AM May-22-23 12:31PM 12:29PM May-21-23 09:00AM May-19-23 05:40AM May-18-23 05:45PM 05:26PM 11:41AM 10:39AM 09:15AM 07:00AM 05:56AM 05:45AM 04:19AM May-17-23 02:47PM 02:29PM 08:48AM May-16-23 09:12AM May-15-23 02:56PM May-11-23 11:26PM 11:21PM 10:13PM 05:45PM 12:37PM May-10-23 03:39PM 03:39PM 11:18AM 05:15AM May-08-23 03:56PM May-06-23 05:30AM May-05-23 05:45PM May-03-23 07:11PM 04:52PM 11:59AM 05:06AM May-02-23 09:00AM Apr-28-23 09:53AM 09:15AM Apr-27-23 11:30AM 08:30AM 05:46AM Apr-26-23 07:00AM 05:20AM Apr-25-23 02:25PM 06:10AM 05:00AM Apr-24-23 02:31PM 10:58AM Apr-21-23 12:16PM 10:00AM Apr-20-23 11:29AM 05:06AM Apr-19-23 09:00AM (The Wall Street Journal)
Apr-17-23 10:31AM 09:00AM Apr-16-23 10:24AM Apr-14-23 09:37AM 07:30AM Apr-13-23 08:00AM 05:06AM Apr-12-23 08:00AM Apr-11-23 09:20AM Apr-10-23 12:33PM 10:24AM 09:00AM 08:56AM
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. 10% Owner May 11 Sale 170.77 292,792 50,000,090 33,366,388 May 15 05:18 PM BREWER ROSALIND G CEO Mar 29 Buy 33.95 10,000 339,510 369,945 Mar 31 04:26 PM Walgreens Boots Alliance, Inc. 10% Owner Mar 01 Sale 30.30 15,475,166 468,897,530 10,771,926 Mar 03 04:43 PM Walgreens Boots Alliance, Inc. 10% Owner Dec 08 Sale 165.08 5,961,534 984,130,033 33,659,180 Dec 12 05:26 PM Ban Kevin M. EVP, Chief Medical Officer Nov 18 Option Exercise 34.04 10,303 350,714 38,219 Nov 22 08:20 PM Ban Kevin M. EVP, Chief Medical Officer Nov 18 Sale 40.19 10,303 414,108 27,916 Nov 22 08:20 PM SCHLICHTING NANCY M Director Nov 17 Sale 39.89 16,570 660,928 5,515 Nov 21 06:11 PM Walgreens Boots Alliance, Inc. 10% Owner Nov 07 Sale 154.60 13,234,153 2,046,000,054 39,629,714 Nov 09 08:00 AM Walgreens Boots Alliance, Inc. 10% Owner Aug 16 Sale 33.01 11,000,000 363,110,000 26,247,092 Aug 18 04:29 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
